Is LeMaitre Vascular Stock a Good Investment?
LeMaitre Vascular Investment Advice | LMAT |
- Examine LeMaitre Vascular's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research LeMaitre Vascular's leadership team and their track record. Good management can help LeMaitre Vascular navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Health Care Equipment & Supplies space and any emerging trends that could impact LeMaitre Vascular's business and its evolving consumer preferences.
- Compare LeMaitre Vascular's performance and market position to its competitors. Analyze how LeMaitre Vascular is positioned in terms of product offerings, innovation, and market share.
- Check if LeMaitre Vascular pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about LeMaitre Vascular's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in LeMaitre Vascular stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if LeMaitre Vascular is a good investment.
Sell | Buy |
Hold
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
Examine LeMaitre Vascular Stock
Researching LeMaitre Vascular's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 96.0% of the company shares are owned by institutional investors. The company has Price/Earnings To Growth (PEG) ratio of 2.19. LeMaitre Vascular last dividend was issued on the 13th of March 2025.
To determine if LeMaitre Vascular is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding LeMaitre Vascular's research are outlined below:
| LeMaitre Vascular generated a negative expected return over the last 90 days | |
| Over 96.0% of the company shares are owned by institutional investors | |
| Latest headline from gurufocus.com: Acquisition by Jasinski Lawrence J of 204 shares of LeMaitre Vascular subject to Rule 16b-3 |
LeMaitre Vascular Quarterly Liabilities And Stockholders Equity |
|
LeMaitre Vascular uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in LeMaitre Vascular. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to LeMaitre Vascular's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 22nd of February 2024 Upcoming Quarterly Report | View | |
| 7th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 22nd of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact LeMaitre Vascular's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises LeMaitre Vascular's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2016-05-02 | 2016-03-31 | 0.1 | 0.11 | 0.01 | 10 | ||
2014-04-29 | 2014-03-31 | 0.02 | 0.01 | -0.01 | 50 | ||
2013-10-29 | 2013-09-30 | 0.04 | 0.05 | 0.01 | 25 | ||
2013-07-30 | 2013-06-30 | 0.05 | 0.06 | 0.01 | 20 | ||
2013-02-26 | 2012-12-31 | 0.05 | 0.04 | -0.01 | 20 | ||
2012-07-31 | 2012-06-30 | 0.04 | 0.05 | 0.01 | 25 | ||
2011-10-27 | 2011-09-30 | 0.07 | 0.06 | -0.01 | 14 | ||
2011-07-28 | 2011-06-30 | 0.08 | 0.07 | -0.01 | 12 |
Know LeMaitre Vascular's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as LeMaitre Vascular is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading LeMaitre Vascular backward and forwards among themselves. LeMaitre Vascular's institutional investor refers to the entity that pools money to purchase LeMaitre Vascular's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Northern Trust Corp | 2024-12-31 | 327.8 K | T. Rowe Price Associates, Inc. | 2024-12-31 | 284.8 K | Driehaus Capital Management Llc | 2024-12-31 | 263.2 K | Envestnet Asset Management Inc | 2024-12-31 | 259.4 K | Acadian Asset Management Llc | 2024-12-31 | 236.8 K | Rice Hall James & Associates, Llc | 2024-12-31 | 235.1 K | Goldman Sachs Group Inc | 2024-12-31 | 206.6 K | Charles Schwab Investment Management Inc | 2024-12-31 | 195.8 K | Kayne Anderson Rudnick Investment Management Llc | 2024-12-31 | 193.1 K | Blackrock Inc | 2024-12-31 | 3.9 M | Conestoga Capital Advisors, Llc | 2024-12-31 | 1.7 M |
LeMaitre Vascular's market capitalization trends
The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.88 B.Market Cap |
|
LeMaitre Vascular's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.10 | 0.06 | |
| Return On Capital Employed | 0.10 | 0.06 | |
| Return On Assets | 0.08 | 0.04 | |
| Return On Equity | 0.13 | 0.14 |
Determining LeMaitre Vascular's profitability involves analyzing its financial statements and using various financial metrics to determine if LeMaitre Vascular is a good buy. For example, gross profit margin measures LeMaitre Vascular's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of LeMaitre Vascular's profitability and make more informed investment decisions.
LeMaitre Vascular's Earnings Breakdown by Geography
Please note, the imprecision that can be found in LeMaitre Vascular's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of LeMaitre Vascular. Check LeMaitre Vascular's Beneish M Score to see the likelihood of LeMaitre Vascular's management manipulating its earnings.
Evaluate LeMaitre Vascular's management efficiency
LeMaitre Vascular has return on total asset (ROA) of 0.0727 % which means that it generated a profit of $0.0727 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1387 %, meaning that it created $0.1387 on every $100 dollars invested by stockholders. LeMaitre Vascular's management efficiency ratios could be used to measure how well LeMaitre Vascular manages its routine affairs as well as how well it operates its assets and liabilities. Return On Equity is likely to gain to 0.14 in 2025, whereas Return On Tangible Assets are likely to drop 0.06 in 2025. At this time, LeMaitre Vascular's Total Current Liabilities is comparatively stable compared to the past year. Liabilities And Stockholders Equity is likely to gain to about 579.4 M in 2025, whereas Non Current Liabilities Other is likely to drop slightly above 246.1 K in 2025.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 15.02 | 15.77 | |
| Tangible Book Value Per Share | 10.49 | 11.01 | |
| Enterprise Value Over EBITDA | 33.39 | 35.06 | |
| Price Book Value Ratio | 6.13 | 4.73 | |
| Enterprise Value Multiple | 33.39 | 35.06 | |
| Price Fair Value | 6.13 | 4.73 | |
| Enterprise Value | 1.2 B | 1.1 B |
Evaluating the management effectiveness of LeMaitre Vascular allows investors to assess its financial health and operational efficiency. Coupled with an analysis of its growth prospects and the current market dynamics, we evaluate the stock's true value and future potential. Key indicators such as revenue, earnings or debt levels are examined alongside external factors like economic trends and regulatory changes. The LeMaitre Stock analysis seeks to determine whether the stock is undervalued, appropriately priced, or overvalued, thereby guiding your investment decisions.
Basic technical analysis of LeMaitre Stock
As of the 24th of March, LeMaitre Vascular secures the mean deviation of 1.67, and Risk Adjusted Performance of (0.09). Concerning fundamental indicators, the technical analysis model lets you check available technical drivers of LeMaitre Vascular, as well as the relationship between them.LeMaitre Vascular's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific LeMaitre Vascular insiders, such as employees or executives, is commonly permitted as long as it does not rely on LeMaitre Vascular's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases LeMaitre Vascular insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
LeMaitre Vascular's Outstanding Corporate Bonds
LeMaitre Vascular issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. LeMaitre Vascular uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most LeMaitre bonds can be classified according to their maturity, which is the date when LeMaitre Vascular has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Understand LeMaitre Vascular's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing LeMaitre Vascular's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | (0.09) | |||
| Market Risk Adjusted Performance | (0.37) | |||
| Mean Deviation | 1.67 | |||
| Coefficient Of Variation | (904.58) | |||
| Standard Deviation | 2.29 | |||
| Variance | 5.25 | |||
| Information Ratio | (0.09) | |||
| Jensen Alpha | (0.22) | |||
| Total Risk Alpha | (0.09) | |||
| Treynor Ratio | (0.38) | |||
| Maximum Drawdown | 10.56 | |||
| Value At Risk | (3.83) | |||
| Potential Upside | 2.4 | |||
| Skewness | (1.32) | |||
| Kurtosis | 3.27 |
| Risk Adjusted Performance | (0.09) | |||
| Market Risk Adjusted Performance | (0.37) | |||
| Mean Deviation | 1.67 | |||
| Coefficient Of Variation | (904.58) | |||
| Standard Deviation | 2.29 | |||
| Variance | 5.25 | |||
| Information Ratio | (0.09) | |||
| Jensen Alpha | (0.22) | |||
| Total Risk Alpha | (0.09) | |||
| Treynor Ratio | (0.38) | |||
| Maximum Drawdown | 10.56 | |||
| Value At Risk | (3.83) | |||
| Potential Upside | 2.4 | |||
| Skewness | (1.32) | |||
| Kurtosis | 3.27 |
Consider LeMaitre Vascular's intraday indicators
LeMaitre Vascular intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of LeMaitre Vascular stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
LeMaitre Vascular Corporate Filings
F3 | 21st of March 2025 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
F4 | 14th of March 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
10K | 28th of February 2025 Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance | ViewVerify |
8K | 27th of February 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
LeMaitre Stock media impact
Far too much social signal, news, headlines, and media speculation about LeMaitre Vascular that are available to investors today. That information is available publicly through LeMaitre media outlets and privately through word of mouth or via LeMaitre internal channels. However, regardless of the origin, that massive amount of LeMaitre data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of LeMaitre Vascular news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of LeMaitre Vascular relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to LeMaitre Vascular's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive LeMaitre Vascular alpha.
LeMaitre Vascular Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards LeMaitre Vascular can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
LeMaitre Vascular Maximum Pain Price Across June 20th 2025 Option Contracts
LeMaitre Vascular's options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of LeMaitre Vascular close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of LeMaitre Vascular's options.
LeMaitre Vascular Corporate Executives
Elected by the shareholders, the LeMaitre Vascular's board of directors comprises two types of representatives: LeMaitre Vascular inside directors who are chosen from within the company, and outside directors, selected externally and held independent of LeMaitre. The board's role is to monitor LeMaitre Vascular's management team and ensure that shareholders' interests are well served. LeMaitre Vascular's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, LeMaitre Vascular's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Joseph Pellegrino | CFO, Principal Accounting Officer and Secretary | Profile |
Additional Tools for LeMaitre Stock Analysis
When running LeMaitre Vascular's price analysis, check to measure LeMaitre Vascular's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LeMaitre Vascular is operating at the current time. Most of LeMaitre Vascular's value examination focuses on studying past and present price action to predict the probability of LeMaitre Vascular's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LeMaitre Vascular's price. Additionally, you may evaluate how the addition of LeMaitre Vascular to your portfolios can decrease your overall portfolio volatility.